58 Biggest Movers From Yesterday
Gainers
Adagio Therapeutics, Inc. (NASDAQ: ADGI) shares jumped 123.3% to settle at $14.18 on Thursday after traders circulated rumors of a reiterated Buy rating and $46 price target from Jefferies.
What 12 Analyst Ratings Have To Say About Ambarella
Over the past 3 months, 12 analysts have published their opinion on Ambarella (NASDAQ:AMBA) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
Stifel Maintains Buy on Ambarella, Raises Price Target to $215
Stifel analyst Tore Svanberg maintains Ambarella (NASDAQ:AMBA) with a Buy and raises the price target from $200 to $215.
Deutsche Bank Maintains Hold on Ambarella, Raises Price Target to $155
Deutsche Bank analyst Ross Seymore maintains Ambarella (NASDAQ:AMBA) with a Hold and raises the price target from $115 to $155.
Morgan Stanley Maintains Overweight on Ambarella, Raises Price Target to $229
Morgan Stanley analyst Joseph Moore maintains Ambarella (NASDAQ:AMBA) with a Overweight and raises the price target from $222 to $229.